Colorectal Cancer Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.

The data presented below is included in the CoC's quality of care measures for colon and rectal cancer, and are for 2015, the most recent year for which data is available. (Data provided by the National Cancer Database.)

The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below measures. For more information about quality and safety measures, see Quality Care.

Adjuvant chemotherapy considered within four months of diagnosis with AJCC Stage III (lymph node positive) colon cancer (when appropriate)

UC San Diego Health95.0%
State of California85.7%
Pacific Region87.8%
Teaching Hospitals87.3%
All Commission on Cancer Approved Programs88.8%

At least 12 regional lymph nodes removed and examined for resected colon cancer

UC San Diego Health94.4%
State of California92.7%
Pacific Region93.2%
Teaching Hospitals93.8%
All Commission on Cancer Approved Programs92.2%

Chemo and radiation therapy, administered or recommended for resected rectal cancers

UC San Diego Health92.3%
State of California87.9%
Pacific Region89.5%
Teaching Hospitals87.7%
All Commission on Cancer Approved Programs87.8%

Appointments & Referrals


La Jolla

Meet Our Specialists